CHC Healthcare Group (TPE:4164)
Taiwan · Delayed Price · Currency is TWD 30.30
-0.40 (-1.30%)
At close: Mar 27, 2026
CHC Healthcare Group Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,398 | 3,601 | 3,877 | 2,974 | 2,440 | |
Revenue Growth (YoY) | 22.16% | -7.13% | 30.35% | 21.92% | -4.52% |
Cost of Revenue | 3,249 | 2,841 | 2,809 | 2,072 | 1,590 |
Gross Profit | 1,149 | 759.13 | 1,068 | 902.31 | 849.48 |
Selling, General & Admin | 737.95 | 522.46 | 454.41 | 422.4 | 355.84 |
Operating Expenses | 750.98 | 520.42 | 454.68 | 426.55 | 356.15 |
Operating Income | 397.8 | 238.71 | 613.48 | 475.76 | 493.33 |
Interest Expense | -110.27 | -87.58 | -77.34 | -58.89 | -50.18 |
Interest & Investment Income | 21.43 | 26.86 | 22.25 | 16.04 | 11.01 |
Earnings From Equity Investments | -5.28 | 1 | 1.6 | -0.33 | 8.64 |
Currency Exchange Gain (Loss) | 8.3 | 7.59 | -5.34 | 19.69 | 1.77 |
Other Non Operating Income (Expenses) | 11.65 | 37.28 | -7.14 | -6.24 | -4.16 |
EBT Excluding Unusual Items | 323.63 | 223.86 | 547.51 | 446.02 | 460.4 |
Gain (Loss) on Sale of Investments | -4.45 | 4.03 | 13.09 | -17.99 | -0.96 |
Gain (Loss) on Sale of Assets | -6.78 | 2.09 | -1.33 | 55.81 | 31.5 |
Other Unusual Items | 0.24 | -6.97 | 0.16 | - | 0.13 |
Pretax Income | 312.65 | 223.01 | 559.43 | 483.84 | 491.07 |
Income Tax Expense | 86.8 | 40.43 | 134.19 | 95.19 | 110.79 |
Earnings From Continuing Operations | 225.85 | 182.58 | 425.24 | 388.65 | 380.28 |
Minority Interest in Earnings | -39.57 | -14.19 | -6.37 | -32.08 | 1.35 |
Net Income | 186.28 | 168.38 | 418.87 | 356.57 | 381.63 |
Net Income to Common | 186.28 | 168.38 | 418.87 | 356.57 | 381.63 |
Net Income Growth | 10.63% | -59.80% | 17.47% | -6.57% | 4.16% |
Shares Outstanding (Basic) | 186 | 167 | 164 | 161 | 157 |
Shares Outstanding (Diluted) | 195 | 195 | 194 | 192 | 186 |
Shares Change (YoY) | 0.33% | 0.55% | 0.92% | 3.31% | -7.82% |
EPS (Basic) | 1.00 | 1.01 | 2.55 | 2.21 | 2.43 |
EPS (Diluted) | 1.00 | 0.98 | 2.26 | 1.98 | 2.18 |
EPS Growth | 1.65% | -56.59% | 14.30% | -9.38% | 11.66% |
Free Cash Flow | 134.33 | -331.72 | 412.92 | -25.97 | 178.7 |
Free Cash Flow Per Share | 0.69 | -1.70 | 2.13 | -0.14 | 0.96 |
Dividend Per Share | 1.100 | 1.510 | 2.010 | 1.968 | 2.011 |
Dividend Growth | -27.15% | -24.88% | 2.11% | -2.12% | 0.05% |
Gross Margin | 26.12% | 21.08% | 27.55% | 30.34% | 34.82% |
Operating Margin | 9.04% | 6.63% | 15.82% | 16.00% | 20.22% |
Profit Margin | 4.23% | 4.68% | 10.80% | 11.99% | 15.64% |
Free Cash Flow Margin | 3.05% | -9.21% | 10.65% | -0.87% | 7.32% |
EBITDA | 1,005 | 847.67 | 1,187 | 959.56 | 941.04 |
EBITDA Margin | 22.85% | 23.54% | 30.63% | 32.26% | 38.57% |
D&A For EBITDA | 607.15 | 608.96 | 573.89 | 483.8 | 447.71 |
EBIT | 397.8 | 238.71 | 613.48 | 475.76 | 493.33 |
EBIT Margin | 9.04% | 6.63% | 15.82% | 16.00% | 20.22% |
Effective Tax Rate | 27.76% | 18.13% | 23.99% | 19.67% | 22.56% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.